These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20237938)

  • 21. Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model.
    Takakura K; Shibazaki Y; Yoneyama H; Fujii M; Hashiguchi T; Ito Z; Kajihara M; Misawa T; Homma S; Ohkusa T; Koido S
    PLoS One; 2015; 10(12):e0142981. PubMed ID: 26642349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
    Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
    Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of ankyrin-B expression reduces growth and invasion of human pancreatic ductal adenocarcinoma.
    Chen Y; Löhr M; Jesnowski R
    Pancreatology; 2010; 10(5):586-96. PubMed ID: 21042036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
    Tan X; Egami H; Ishikawa S; Sugita H; Kamohara H; Nakagawa M; Nozawa F; Abe M; Ogawa M
    Int J Oncol; 2005 May; 26(5):1283-9. PubMed ID: 15809719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
    Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
    Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
    Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
    Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic cancer biology and genetics.
    Bardeesy N; DePinho RA
    Nat Rev Cancer; 2002 Dec; 2(12):897-909. PubMed ID: 12459728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
    Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
    Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.
    Rhim AD; Stanger BZ
    Prog Mol Biol Transl Sci; 2010; 97():41-78. PubMed ID: 21074729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasion and metastasis in pancreatic cancer.
    Keleg S; Büchler P; Ludwig R; Büchler MW; Friess H
    Mol Cancer; 2003 Jan; 2():14. PubMed ID: 12605717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pancreatic tumor: progress in diagnosis and treatment. Topics: I. Pancreatic carcinoma: 2. Pathogenesis and pathobiology in pancreatic cancer.--The molecular mechanisms of carcinogenesis, and invasion and metastasis in pancreatic cancer].
    Satoh K; Shimosegawa T
    Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):7-16. PubMed ID: 22413456
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular pathogenesis of pancreatic cancer: advances and challenges.
    Welsch T; Kleeff J; Friess H
    Curr Mol Med; 2007 Aug; 7(5):504-21. PubMed ID: 17691965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Models of pancreatic ductal adenocarcinoma.
    Dennaoui R; Shrestha H; Wagner KU
    Cancer Metastasis Rev; 2021 Sep; 40(3):803-818. PubMed ID: 34491463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Heterogeneity in Pancreatic Adenocarcinoma.
    Cros J; Raffenne J; Couvelard A; Poté N
    Pathobiology; 2018; 85(1-2):64-71. PubMed ID: 28787741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances from genetic clues in pancreatic cancer.
    Kern SE
    Curr Opin Oncol; 1998 Jan; 10(1):74-80. PubMed ID: 9466488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Events in the Natural History of Pancreatic Cancer.
    Oldfield LE; Connor AA; Gallinger S
    Trends Cancer; 2017 May; 3(5):336-346. PubMed ID: 28718411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer.
    Cano CE; Sandí MJ; Hamidi T; Calvo EL; Turrini O; Bartholin L; Loncle C; Secq V; Garcia S; Lomberk G; Kroemer G; Urrutia R; Iovanna JL
    EMBO Mol Med; 2012 Sep; 4(9):964-79. PubMed ID: 22821859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.